Embecta (Nasdaq:EMBC) stock was down today after news of restructuring and mixed second-quarter results. Shares of EMBC were down more than 8% to $12.12 apiece near the close of trading today.

Solventum, spun off from 3M in April 2024, reported $2.1 billion in sales for the first quarter of 2025, an increase of 2.6%.

The Andover, Massachusetts–based medtech company, which offers an organ care system (OCS) for transplant therapy, hit $143.5 ...

Globus Medical stock is down today on an unexpectedly soft Q1 amid an earlier-than-planned integration with recently acquired ...

German medtech giant Siemens Healthineers reduced the lower end of its full-year earnings guidance amid Trump administration ...

SS Innovations plans to submit a de novo classification request to the U.S. FDA for its SSi Mantra 3 surgical robotic system.

Enovis beat earnings expectations in its first quarter 2025 results out today, but the market reaction was tempered.

MicroTransponder has reported the results of a one-year follow-up study of its Vivistim Paired VNS System for chronic stroke ...

Bausch + Lomb announced today that it received CE mark approval for its LuxLife full range of vision intraocular lens (IOL).

Boston Scientific (NYSE: BSX) + Boston Scientific Corp. $104.068 0.15% Open 104.222 Day High 104.79 52 Week High 79.43 52 ...

Imperative Care announced today that it expanded its Zoom Stroke System with the launch of its Zoom DuoPort technology.

BrightHeart has its second FDA clearance for updates to its platform, an AI-powered digital screening tool for congenital ...